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Type C retroviruses have been implicated in tbe etiology of naturally occurring 
leukemias and lymphomas in several animal species. The extensive search for a 
possible retroviral etiology of some human leukemias and lymphomas has led to 
the  first isolation  of a  novel  type C  retrovirus,  human T  cell  leukemia virus 
(HTLV), l from cultured human neoplastic T  cells (1-3). 
Recently, a type C retrovirus (ATLV) has been isolated from the cultured cells 
of adult T  cell leukemia (ATL), a  unique lymphoproliferative disease of T  cell 
origin  that  has  been  recognized  in Japan  (4-9).  ATLV  seems  to  be  causally 
related to ATL and is a member of the HTLV group (10-15).  HTLV has been 
reported  to  have  immortalizing effects on  normal  human,  simian, and  rabbit 
lymphocytes (16-21).  In this paper, we report that HTLV successfully infected 
and immortalized rat  lymphoid cells of the spleen,  lymph nodes, and  thymus 
when cocultivated with 5-bromo-2'-deoxyuridine (BrdUrd)-treated  ATL cells. 
Furthermore, two of these cell lines established in vitro were transformed and 
transplantable into newborn syngeneic rats as well as into nude mice. Adult rats 
that rejected these cell lines, after repeated immunizations, produced high titered 
antibodies against HTLV. 
Materials and Methods 
Animals.  Inbred  Wistar-King-Aptekman (WKA/Hok) rats were kindly supplied  by 
Prof. M.  Aizawa  (Department of Pathology, Hokkaido University School of Medicine, 
Sapporo, Japan).  Nude mice (BALB/c-nu/nu) were obtained from the Department of 
Genetics and Breedings, Central Institute for Experimental Animals, Tokyo, Japan. 
Antisera.  ATL patients' sera that contained high titered antibodies for ATL-associated 
antigen (ATLA) were used. Rabbit anti-Ra-1  serum (22) that contained specific antibodies 
for  the  structural  proteins  of HTLV  was  generously provided  by  Prof.  I.  Miyoshi 
(Department  of Medicine,  Kochi  Medical  College,  Kochi, Japan).  The  monospecific 
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antisera for structural proteins, gp70, p30, and p 15(E) of murine type C virus (Rauscher), 
p30 of feline type C virus, and p30 of simian type C virus (SSV-1) were prepared in rabbits 
or in goats and generously provided by Drs.  W.  D. Hardy, Jr., E.  Fleissner (Memorial 
Sloan-Kettering Cancer Center, New York), and J. T. August (Johns Hopkins University, 
School of Medicine, Baltimore, MD). The specificity of these antisera for immunofluores- 
cence reaction was confirmed by the absorption of the antisera with either intact virus 
particles or purified viral proteins (23-25). 
Cells.  Fresh ATL cells were obtained from the heparinized blood of a  68-year old 
male ATL patient using the Ficoll-Paque (Pharmacia, Sweden) gradient. The patient had 
leukocyte counts  of  106,700/mm s of which  >90%  were  ATL cells with  indented  or 
lobulated  nuclei.  Anti-ATLA titer in  the serum was  1:1,280.  The surface markers of 
leukemic  cells  were  Leu-l(+),  Leu-2a(-),  Leu-3a(+),  Leu-5(+),  Leu-7(-),  Leu-10(-), 
surface Ig(-), HLA-DR(-), and Leu-Ml(-). 
Cell suspensions of female WKA rats were prepared according to the method described 
elsewhere (26).  After several washings,  the cells were finally suspended in RPMI  1640 
supplemented with 20% heat-inactivated fetal calf serum (FCS),  penicillin (100 IU/ml), 
and streptomycin (100/~g/ml). 
Tissue  homogenates  for  absorption  tests  were  prepared  according  to  the  method 
described elsewhere (23). 
Short-term Culture of ATL Cells in the Presence of 5-Bromo-2'-deoxyuridine (BrdUrd).  Fresh 
ATL cells were placed in tissue culture flasks (Corning, NY) at a density of 5 ×  106/ml 
in RPMI-1640 medium supplemented with  20%  FCS containing  50 #g/ml of BrdUrd 
(Sigma Chemical Co., St. Louis, MO). They were incubated at 37°C for 3 d in a humidified 
5% COs atmosphere. The cells were washed twice with cold Hanks' balanced salt solution 
and used for either cocultivation study or electron microscopic observation. 
Cocultivation.  First, spleen cells, lymph node cells, and thymocytes of female WKA rats 
were  cultured  at  a  density  of  1  ×  106/ml  in  tissue  culture  flasks  with  RPMI-1640 
supplemented with 20% FCS for 9 d. An equal volume of washed ATL cell suspension (1 
6  x  10/ml) pretreated with BrdUrd was then added to each culture flask. Control cultures 
included one culture flask each of the rat spleen cells, lymph node cells, thymocytes, and 
ATL  cells  pretreated  with  BrdUrd  alone.  All  cultures  were  incubated  at  37°C  in  a 
humidified 5% CO2 atmosphere and fed twice a week. 
Cell Lines.  The HTLV-producer human cell lines MT-1 (6) and MT-2 (8) were kindly 
supplied by I. Miyoshi. The HTLV-negative cell lines Molt-4F and EB-Wa were kindly 
provided by Dr. H. Ikeda (Asahikawa Medical College, Asahikawa, Japan). The HTLV- 
producer rat lymphoid lines TARS-l, TARL-2, and TART-l, will be described in the 
text. 
Immunofluorescence (IF) Analysis.  Indirect  IF tests of acetone-fixed cells for murine, 
feline, and simian type C  viral proteins, and for ATLA were performed as previously 
described (7, 24).  Anti-ATLA antibodies were titrated with acetone-fixed MT-2/Molt-4F 
cells. Briefly, one portion of ATLA-positive MT-2 cell suspension (1 x  106/ml) and three 
portions of ATLA-negative Molt-4F cell suspension (1  x  106/ml) were mixed and the 
cells were dropped onto muitispot microscopic slides (C. A. Hendley Ltd., Essex, England). 
The slides were incubated overnight on wet filter paper in a large, clean petri dish. After 
a quick rinse with PBS and distilled water, the cells were fixed in cold acetone for 10 rain 
and allowed to air dry.  Selective IF staining of ~25%  of the fixed cells was a  positive 
indication for anti-ATLA antibodies. 
Membrane IF tests for rat cell surface markers were kindly performed by Drs. Y. Ishii, 
A. Matsuura, and Prof. K. Kikuchi, Department of Pathology, Sapporo Medical College, 
Sapporo, Japan, as described elsewhere (27). 
Absorption Test.  The specificity of IF reactions with rat anti-TARL-2 serum (see text) 
was confirmed by absorption tests with cell lines, rat cells, and homogenates. The method 
for absorption was described elsewhere (23). 
Transplantability of Rat Cell Lines into Newborn Syngeneic Rats and Nude Mice.  Newborn 
WKA rats were injected intraperitoneally with either viable TARS-1, TARL-2, or TART- 
1 cells in doses of 1 X  10  7 cells.  Rats were examined at 2 wk for histology. Nude mice TATENO ET AL.  1107 
were inoculated subcutaneously with either viable TARS-l, TARL-2, or TART-1 cells in 
doses of 1 ×  107 cells. 
Immunization of Adult Syngeneic Rats with Rat Cell Lines.  Adult WKA rats were injected 
intraperitoneaily with either TARS-1 or TARL-2 cells in doses of 1 ×  107 cells, followed 
by an intravenous injection into tail vein at the same dosage at 1-wk intervals. After being 
injected five times, the rats were bled to death. The sera were collected and stored at 
-70°C until use. 
Labeling of Cells and SDS-PAGE Analysis.  Labeling of MT-2 cells with metabolic pre- 
cursor, [sSS]methionine (Amersham Co. Ltd.), was carried out according to the method 
described (28).  The  labeled  cell  suspension  was  washed  three  times  with  phosphate- 
buffered saline and the cells were lysed with RIPA lysis buffer (0.15 M NaCI;  0.5 mM 
MgCI2, 0.6  M  KCi,  1 mM phenylmethyisulfonylfluoride, 10,000  KU/100 ml Trasylol 
Aprotinin, 10 mM Tris-HCl, pH 7.8) containing 2% Triton X-100. The soluble extracts 
were cleared by centrifugation at 25,000 g for 15 min at 4°C. Before precipitation of 
viral  immunoreactive proteins,  the  soluble  extracts  were  incubated  with  anti-ATLA 
negative human or rat serum for 16 h at 4°C at a ratio of 35/zl of serum to 100 ~1 of cell 
extract. The IgG in the mixture was removed with protein A-Sepharose 4B (Pharmacia 
Fine Chemicals, Piscataway, NJ). After centrifugation, the supernatant was then incubated 
for 4  h  at 4°C  with  20  ~1 of various sera with or without antibodies against  HTLV- 
structural  proteins.  After  further incubation with  protein  A  for 45  rain  at  40C,  the 
immune complexes were precipitated by centrifugation. They were washed twice and 
resuspended in 70 #i of electrophoresis sample buffer (0.0625 M Tris-HCI, pH 6.8, 2% 
SDS, 4% mercaptoethanol) and heated for 3 rain in a boiling water bath. After addition 
of 10% glycerol and 0.05% bromophenol blue, the samples were electrophoresed in SDS- 
polyacrylamide slab gels and prepared for fluorography. A sample containing 14C-labeled 
bovine serum albumin (tool wt 69,000), ovalbumin (rnol wt 46,000), carbonic anhydrase 
(tool wt 30,000), and lysozyme (tool wt  14,300) was simultaneously run as a molecular 
weight marker (Amersham Co. Ltd.). 
Electron Microscopy.  For electron microscopy, cell pellets and tissues  were fixed in 2% 
glutaraldehyde, postfixed in 2% osmium tetroxide, dehydrated, and embedded in Epon 
812. Ultrathin sections were stained with uranyl acetate, followed by lead nitrate, and 
examined in a Hitachi H-600 electron microscope. 
Cytogenetic Analysis.  Cytogenetic  studies  were  performed on  rat  cell  lines  without 
phytohemagglutinin. The cells were incubated in the presence of colcemid, 0.02/zg/ml, 
for 3 h at 37 °C, and then treated with hypotonic solution for 15 rain at room temperature, 
and fixed in methanol-acetic acid (3:1). Chromosome preparations were made using flame- 
drying techniques. Chromosomes were stained with conventional Giemsa and analyzed 
under usual light microscopy. 
Light Microscopy.  The cells were  stained  with  May-Grfinwald-Giemsa and periodic- 
acid/Schiff  (PAS) and for a-naphthyl acetate esterase and acid-phosphatase activity by the 
usual cytochemical techniques. Tissues of WKA rats were fixed in  10% formalin. Four 
stains were used: hematoxylin and eosin, periodin acid Schiff (PAS), silver impregnation, 
and methyl green pyronin. 
Results 
Establishment of Rat Lymphoid Cell Lines by Superinfection  with HTLV.  1 wk after 
the cocultivation of female rat spleen cells with BrdUrd-treated ATL cells, small 
clumps  of cells began  to appear  and  gradually  increased  in  size and  number. 
After two months, the cells began to proliferate vigorously in suspension forming 
large clumps of cells, and have since been maintained in continuous culture for 
over 8 months. This cell line was designated TARS-1. The TARS-1 cells grown 
in suspension had a  tendency to clump and to adhere to the plastic.  The cells 
were  generally  round  or  ovoid  and  varied  in  size  with  a  modest  amount  of 
agranular cytoplasm. The nuclei were mostly oval and nucleoli were indistinct. 1108  HUMAN RETROVIRUS PRODUCER RAT CELL LINES 
The modal cell diameter was  12 #m.  The majority of cells were PAS reaction 
negative, but occasional cells showed granular PAS positivity in the cytoplasm. 
The  cells  were  uniformly and  intensely stained  for acid  phosphatase,  which 
appeared as paranuclear large roundish  clumps,  indicating that  TARS-1  is  a 
rather homogeneous population  (Fig.  1 A). The cells were also weakly positive 
for a-naphthyi acetate esterase. Cytogenetic analysis of TARS-1 showed a female 
rat karyotype with 42 chromosomes (Fig.  1 B). 
Subsequently, we succeeded in establishing two rat lymphoid cell lines, TARL- 
2 and TART-l, which originated in the lymph node and thymus, respectively. 
Both  cell lines grew in  suspension and formed clumps without a  tendency to 
adhere to the plastic.  Both cell lines were uniformly and intensely stained for 
acid phosphatase, which appeared as paranuclear large roundish clumps. Cyto- 
genetic analysis of TARL-2 and TART-1  showed a  female rat karyotype with 
42 chromosomes. Rat spleen cells, lymph node cells, thymocytes, or pretreated 
ATL cells alone did not grow and degenerated within 2 months. 
Cell Surface Markers.  The results of surface marker tests, which were used to 
characterize rat and human lymphocytes, are summarized in Table I. TARS-1 
cells were positive for rat Thy-1, Ly-1, Ia, and leukocyte common antigens, but 
negative for rat Ly-2, surface Ig, and human Leu-1 antigens. TART-1 cells were 
positive for rat Thy-1, Ia, and leukocyte common antigens, but negative for rat 
Ly-1, Ly-2, surface Ig, and human Leu-1  antigens. These results indicate that 
TARS-1 and TART-1  originate in rat T  cells. 
TARL-2  cells were positive for rat Ia and leukocyte common antigens, but 
negative for rat Thy-1, Ly-1, Ly-2, surface Ig, and human Leu-1 antigens. 
Expression of Type C  Viral Antigens.  Fixed  cells  of TARS-l,  TARL-2,  and 
TART-1 were examined for the expression of various type C retrovirus antigens 
with indirect IF. Three cell lines were only positive for ATLA demonstrated by 
both human sera containing anti-ATLA antibody and rabbit anti-Ra-1  serum. 
~20% of the fixed cells were brightly stained for ATLA in the cytoplasm with 
granular pattern (Fig.  1 C). Tests for the antigens related to murine gp70, p30, 
pl 5(E), feline p30, and SSV-1 p30 were negative in all three cell lines, indicating 
the  unlikelihood  of activation  of rat  endogenous  type C  viruses  which  have 
antigens shared with murine, feline, and simian type C retroviruses. 
Electron Microscopy.  After short-term culturing with BrdUrd, ATL cells pro- 
duced type C virus particles morphologically identical to HTLV. Large numbers 
of mature and immature particles were found in the extracellular space in clumps 
associated with cellular debris. Budding from the cell membrane was also seen. 
TARS-1  cells, sized 8-15 #m in diameter, had a rather uniform oval nucleus. 
Special configurations of the nuclear envelope, such as irregular deep indentation 
or lobulation, were not seen. The chromatin was rather evenly distributed, and 
the nucleoli were prominent. The cell membrane was smooth and the cytoplasm 
was relatively abundant and rich in membranous organelles and in polyribosomes. 
Extracellular type C  virus particles were occasionally seen.  Budding form was 
practically absent. After short-term culturing with BrdUrd, TARS-1  cells pro- 
duced a  considerable number of mature and immature type C  virus particles 
morphologically identical to HTLV in the extracellular space (Fig.  1 D). Occa- FIGURE  1.  Cytologic, cytogenetic, immunofluorescent, and ultrastructural characteristics of 
TARS-1.  (.4) TARS-1  cells uniformly  contain  large  roundish  clumps  of acid phosphatase 
activity in  the cytoplasm (x  1,000).  (B) Cytogenetic analysis of TARS-I  showing a  normal 
female rat karyotype with 42 chromosomes. (C) Detection of ATLA in acetone-fixed TARS- 
1 cells by indirect immunofluorescence. The cells were first treated with ATL patient's serum 
at a  dilution of 1:20 which contained an anti-ATLA antibody titer of 1:1,280  followed by 
fluorescein-conjugated anti-human IgG. Note granular fluorescence in the cytoplasm (x 200). 
(D) Electron micrograph of TARS-1 treated with BrdUrd. Mature and immature type C virus 
particles are seen in the extracellular space associated with cellular debris (Bar, 900 nm). 
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TABLE  I 
Cell Surface Markers 
Human 
Rat markers 
markers 
Cell line  Leuko- 
Thy-1  Ly-1  Ly-2  Ia  cyte  slg  Leu-1 
common 
TARS- 1  +  +  -  +  +  -  - 
TARL-2  -  -  -  +  +  -  - 
TART- 1  +  -  -  +  +  -  - 
sionally, typical type C viruses were observed budding from the cell membrane. 
The other two cell lines showed a similar morphology with virus production. 
Transplantability  of TARS-1  and  TART-1  but  Not  TARL-2  Cells into  Newborn 
Syngeneic Rats and Nude Mice.  To determine whether rat cell lines established 
in  vitro are associated  with cell transformation,  newborn  syngeneic WKA  rats 
were injected intraperitoneally with either TARS-l, TARL-2, or TART-1 cells. 
After  2  wk,  all  the  rats  injected  with  TARS-1  rapidly  deteriorated.  The  rats 
were killed, and the organs were examined histologically. Out of the nine rats 
all showed marked swelling of the mediastinal and mesenteric lymph nodes. The 
paraaortic and the hilar lymph nodes of the spleen were also swollen. The tumor 
nodules were frequently seen at the injection site. Whitish nodules were dissem- 
inated in the parenchyma of the liver and lung. The spleen was slightly enlarged. 
The thymus, bone marrow, and other organs appeared intact. By light micros- 
copy,  lymph  nodes  of the  mediastinum,  mesenterium,  paraaorta,  and  splenic 
hilus were totally replaced by a  massive infiltration of large lymphoblastic cells 
morphologically similar to TARS-1. The subcutaneous nodules at the injection 
site showed a diffuse proliferation of tumor cells with a densely packed arrange- 
ment. The lungs also showed tumor growth, which formed multiple nodules in 
the  parenchyma  (Fig.  2).  The  tumor  cells  infiltrated  mainly along  the  portal 
tract, forming occasional tumor nodules in the liver. The spleen showed micro- 
scopical tumor infiltration. The tumor cells infiltrated diffusely into the omentum 
and pancreas. The thymus and other organs were negative for tumor infiltration. 
TARS-1 cells were not transplantable into adult WKA rats. TARS-1  inoculated 
subcutaneously in nude mice grew slowly forming nodules. After 2 months, the 
nodule  measured  2.0  ×  1.5  ×  1.5  cm.  The  histological  examination  showed 
massive subcutaneous growth of tumor cells resembling TARS-1. TART-1  was 
also  transplantable  into  newborn  syngeneic  rats  and  nude  mice  with  similar 
growth  patterns.  In  contrast,  TARL-2  cells  were  transplantable  into  neither 
newborn and  adult  WKA  rats  nor nude mice.  It was  concluded that  TARS-1 
and TART-1 are cell lines with tumorigenic activity in vivo. 
Production of Specific Antibodies for HTLV in Adult WKA Rats Immunized with Rat 
Cell Lines.  Since TARS-1 and TARL-2 cells were not transplantable into adult 
rats, WKA rats were given i.v. injections of either TARS-1  or TARL-2 cells at 
1-wk  intervals.  The  sera obtained  from hyperimmune  rats  with  TARS-1  cells 
contained  antibodies  for  ATLA  with  a  titer  of  1:640  as  seen  by  IF.  Rats 
immunized with TARL-2 cells also produced high titered antibodies for ATLA TATENO  ET  AL.  1111 
FIGURE 2.  TARS-1  transplanted into a  newborn rat. The tumor infiltrates diffusely in the 
pulmonary parenchyma forming multiple nodules (H&E, x  100). 
TABLE  II 
IF Specificity of Antigens Demonstrated with Rat Anti-TARL-2 Serum 
Antigens used for absorption 
Residual antibody 
activity* on fixed  Result of 
MT-2/Molt-4F  absorption 
cells 
WKA rat 
Thymus  ++  - 
Spleen  ++  - 
Lymph node  ++  - 
Liver  ++  - 
Kidney  ++  - 
Brain  ++  - 
Erythrocytes  ++  - 
Cultured cells 
MT-2  -  + 
MT-1  -  + 
EB-Wa  ++  - 
Molt-4F  ++  - 
TARS-I  -  + 
TARL-2  -  + 
Fetal calf serum  ++  - 
* Rat  anti-TARL-2  serum  was  used at  a  serum  dilution of 1:250.  The 
residual antibody activity was determined by immunofluorescence (IF). 
with  a  titer  of  1:1,280.  In  order  to  demonstrate  the  antibody  specificity,  rat 
antisera  were  absorbed  with  various  tissues  and  cultured  cells listed  in  Table  II. 
The  absorbed  serum  was  tested  for  residual  antibody  activity  on  fixed  MT-2/ 1112  HUMAN  RETROVIRUS  PRODUCER  RAT  CELL  LINES 
Molt-4F cells by indirect IF.  Cultured cell lines producing HTLV,  MT-2,  MT- 
1, TARS-l, and TARL-2 absorbed the antibody activity. HTLV nonproducer 
cell  lines,  Molt-4F and  EB-Wa,  did not absorb  the antibody activity.  Neither 
normal  rat  cells  and  tissues  nor  FCS  absorbed  the  antibody  activity.  These 
findings strongly indicate that the antigen(s) recognized by rat antisera is specif- 
ically related to HTLV. 
Structural Proteins of  HTLV Demonstrated by Rat Antisera.  Cytoplasmic extracts 
of MT-2 cells labeled with [3~S]methionine were allowed to react with rat anti- 
TARL-2  serum and anti-ATLA-positive human serum.  Anti-ATLA-negative 
human and rat sera were included as negative controls. The antigen-antibody 
complexes were adsorbed onto protein A-Sepharose 4B and then the samples 
were redissolved and analyzed in 10%  SDS PAGE and autoradiography. 
Two polypeptide bands were specifically precipitated with rat anti-TARL-2 
and  anti-ATLA-positive  human  serum.  These  polypeptides  have  molecular 
weights of approximately 28,000  (p28) and 24,000  (p24) daltons (Fig.  3).  P24 
appears  to  be  the major polypeptide demonstrated by both rat anti-TARL-2 
serum and anti-ATLA-positive human serum. 
Discussion 
The present study confirms and expands on the previous findings of Miyoshi 
et al. and others (16-21) that HTLV has a wide range of host animals in that it 
is transmissible not only to human and primate lymphocytes, but also to rabbit 
lymphocytes in  vitro.  In  our  study,  HTLV  preferentially infected and  trans- 
formed rat T  cells of the spleen and thymus. The exact character of TARL-2, 
which originated in the lymph nodes, was not determined since TARL-2 cells 
were only positive for rat Ia and leukocyte common antigens. Nevertheless, the 
present study suggests a tenacious T  cell-tropism of HTLV in a  wide range of 
FIGURE  3.  SDS-PAGE analysis of the immunoprecipitates formed between [s~S]-iabeled MT- 
2 polypeptides and normal rat serum (A), rat anti-TARL-2  serum (B), ATL patient serum (C), 
and normal human serum (D). TATENO ET AL.  1 1 13 
host  animals.  Because  HTLV  is  not  endogenous  in  humans  (3,  9),  a  more 
complete host range study or an analysis of whether or not wild rats are naturally 
infected with HTLV in ATL endemic areas would be of considerable interest. 
It was demonstrated that the ability of TARS-l, TARL-2, and TA'~T-1 to be 
transplanted in vivo differs. TARS-1 and TART-1 cells were transplan,able not 
only in newborn syngeneic rats but also in nude mice, whereas, TARL-2 cells 
did not grow in either newborn syngeneic rats or in nude mice. The evidence 
suggests that TARS-1 and TART-1 are cell lines that have been transformed by 
HTLV. Although the complete nucleotide sequence of the provirus genome has 
been fully determined, the location or even the existence of the transforming 
gene(s) of HTLV is not clear at the present time (29). Nevertheless, the present 
study strongly indicates that HTLV not only immortalizes, but also transforms 
rat T  cells in vitro. Its effect on rat T  cells suggests either that HTLV contains 
a transforming gene or that it activates rat cellular onc.  Studies are under way to 
clarify these points. 
Several researchers have reported the presence of natural antibodies in human 
sera that reacted with the structural proteins of HTLV (7,  9-12,  14,  15,  28). 
The  major  reactive  antigens  they  reacted  with  were  shown  to  be  internal 
structural proteins with molecular weights of 24,000  daltons (p24) and  19,000 
daltons (p19) (9-12,  14,  15, 28). WKA rats immunized with either TARS-1  or 
TARL-2 produced antibodies specific for HTLV-producer cell line, MT-2. The 
biochemical analysis of antigens  that  reacted with  rat  antisera  indicated that 
molecular species bearing antigenic determinants are at least two HTLV-related 
polypeptides,  p24  and  p28.  P24  seems to  be  the  major  core polypeptide  of 
HTLV. Recently, Tanaka et al. (30) have demonstrated, using a mouse mono- 
clonal antibody that reacts with both HTLV-specific polypeptides p19 and p28, 
that both p19 and p28  were found in MT-2 and T  cell lines newly established 
by superinfection with MT-2, whereas only p19 but not p28 was found in MT-2 
unrelated HTLV producer cell lines. They suggested that HTLV-producer cell 
lines can be classified into two groups according to the presence or absence of 
p28  (30),  and combining this  with the fact that attempted transformations of 
normal cells by the superinfection with p28-defective HTLV  producers have 
failed, they presumed that the expression of p28 may have an important function 
in the in vitro transformation of normal cells by HTLV. This may be consistent 
with  the recent finding that  the nucleotide sequence of the  HTLV  provirus 
contains four open reading frames other than those for gag, pol, and env genes. 
One of them could code for 27,000-dalton polypeptide (29).  Determination of 
whether or not p28 that was detected by rat sera as well as human sera containing 
anti-ATLA antibody, is coded by the HTLV genome or related to cell transfor- 
mation will require further research. 
Finally, the establishment of the three rat cell lines with HTLV production 
reported here, TARS-l,  TARL-2, and TART-1  may provide biologically and 
genetically useful information on  HTLV  and the molecular mechanism of its 
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Summary 
Cocultivation  of spleen  cells,  lymph  node  cells,  and  thymocytes of female 
Wistar-King-Aptekman rats with short-term cultured male adult T  cell leukemia 
(ATL) cells in  the  presence of 5-bromo-2'-deoxyuridine (BrdUrd)  resulted  in 
the establishment  of rat lymphoid cell lines,  TARS-l,  TARL-2, and  TART-1. 
Cytogenetic analysis of the three cell lines showed a  female rat karyotype with 
42 chromosomes. The surface phenotypes of TARS-1 and TART-1  were those 
of rat  T  cells.  TARL-2  was  only positive  for  rat  Ia  and  leukocyte  common 
antigens. The cell lines continuously produced a type C retrovirus, human T  cell 
leukemia virus  (HTLV) and  expressed ATL-associated antigens.  TARS-1  and 
TART-l,  but not TARL-2 were transplantable into newborn syngeneic rats and 
nude mice.  These results strongly indicate  that  HTLV  not only immortalizes, 
but also transforms rat T  cells in vitro. Adult rats immunized with either TARS- 
1 or TARL-2 produced antibodies specific for HTLV. The biochemical analysis 
of the antigens that reacted with rat sera revealed that they are the two HTLV- 
specific polypeptides, p24 and p28. 
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